This inventor holds 1 USPTO granted patent. Top assignees: Genfleet Therapeutics (Shanghai) Inc., Zhejiang Genfleet Therapeutics Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 7 
1 out of 2 Years Active: 2026
Title: Lijian Feng - Innovator in Aroyl Substituted Tricyclic Compounds
Introduction
Lijian Feng is an inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of aroyl substituted tricyclic compounds. His work focuses on creating compounds that serve as inhibitors for specific biological targets, showcasing his commitment to advancing pharmaceutical science.
Latest Patent Applications
Lijian Feng has filed a patent application for an aroyl substituted tricyclic compound, along with its preparation method and uses. The disclosed compound is designed to act as a BTK inhibitor, demonstrating high activity, good selectivity, and low toxicity and side effects. This innovative approach has the potential to contribute significantly to therapeutic options in treating various diseases.
Conclusion
Lijian Feng's work in developing aroyl substituted tricyclic compounds highlights his innovative spirit and dedication to improving healthcare solutions. His ongoing research and patent applications reflect his potential to make a lasting impact in the field of medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile